Financial Distress in Advanced Cancer Patients

NCT04053517 | Active Not Recruiting

• 2 other identifiers: 2018-0694NCI-2019-03869
• Study Type: observational
• Target: 141
• Locations: 1 country
• Sites: 1

Brief Summary

This trial studies the severity of financial distress in advanced cancer patients. The cost of cancer care can often be very expensive. Financial distress from the burdens of high costs and debt may interfere with a patient's physical symptoms and quality of life.

Conditions

Advanced Malignant Neoplasm; Locally Advanced Malignant Neoplasm; Metastatic Malignant Neoplasm; Recurrent Malignant Neoplasm; Refractory Malignant Neoplasm

Outcome Measures

Primary Outcomes (1)

• InCharge Financial Distress/Financial Well-Being Scale (IFDFW),

  a validated survey designed to measure a person's financial state, consists of eight questions and each of them is rated from 1 (overwhelming stress) to 10 (no stress at all). This should take approximately 5 minutes to complete.

  Day 1

Secondary Outcomes (4)

• Correlation between high financial distress with clinical characteristics in advance cancer patients

  Day 1

• Correlation between mean scores of In Charge Financial Distress/ Financial Well-Being Scale (IFDFW) and scores from other financial distress instruments

  Day 1

• Correlation between high financial distress with patient symptoms in(ESAS) Edmonton Symptom Assessment System

  Day 1

• Correlation between high financial distress with Quality of life

  Day 1

Study Arms (1)

Observational (questionnaire administration)

Patients complete questionnaires about financial state and quality of life over 15 minutes. Patients' medical chart is also reviewed.

Other: Medical Chart Review; Other: Quality-of-Life Assessment; Other: Questionnaire Administration

Interventions

Medical Chart Review OTHER

Medical chart is reviewed

Also known as: Chart Review

Observational (questionnaire administration)

Quality-of-Life Assessment OTHER

Ancillary studies

Also known as: Quality of Life Assessment

Observational (questionnaire administration)

Questionnaire Administration OTHER

Ancillary studies

Observational (questionnaire administration)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with a diagnosis of advanced cancer

You may qualify if:

• Patient must have a diagnosis of advanced cancer, as defined by recurrent disease, locally advanced disease, metastatic disease, or refractory disease
• Patients must be able to understand, read, write, and speak English
• Patients must have no clinical evidence of severe cognitive impairment (Memorial Delirium Assessment Scale score of \>= 13) and should be able to consent and answer the questionnaires
• Patients must sign an informed consent

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead
• National Cancer Institute (NCI): collaborator

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

• University of Texas MD Anderson Cancer Center Website

MeSH Terms

Conditions

Neoplasm Metastasis; Recurrence; Neoplasms

Condition Hierarchy (Ancestors)

Neoplastic Processes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Disease Attributes

Study Officials

• Jacqueline Tschanz, MD

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 15, 2019
• First Posted: August 12, 2019
• Study Start: July 2, 2019
• Primary Completion (Estimated): December 31, 2027
• Study Completion (Estimated): December 31, 2027
• Last Updated: April 15, 2026

Record last verified: 2026-04

Locations

US (1)